Showing results (1-10 of 149) with videos related to
Sort By:
Pageof 15
Cancer Treatment and Research|January 20, 2018
Immune Checkpoint Blockade for Breast CancerApril Swoboda, Rita NandaBreast Cancer Research and Treatment|July 29, 2017
Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centersCesar A Santa-Maria, Megan Kruse, Paola Raska, et al.Seminars in Oncology|March 23, 2011
"Targeting" triple-negative breast cancer: the lessons learned from BRCA1-associated breast cancersRita NandaReviews on Recent Clinical Trials|May 14, 2008
Targeting the human epidermal growth factor receptor 2 (HER2) in the treatment of breast cancer: recent advances and future directionsRita NandaTherapeutic Advances in Medical Oncology|September 2, 2016
Concepts and targets in triple-negative breast cancer: recent results and clinical implicationsPoornima Saha, Rita NandaClinical Breast Cancer|April 6, 2024
The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC)Elena Michaels, Nan Chen, Rita NandaJournal of the National Comprehensive Cancer Network : JNCCN|October 17, 2018
Immune Checkpoint Inhibitor Therapy in Breast CancerCesar A Santa-Maria, Rita NandaExpert Review of Anticancer Therapy|February 19, 2020
Atezolizumab for the treatment of breast cancerSangeetha M Reddy, Emma Carroll, Rita NandaBreast Cancer Research and Treatment|July 14, 2022
Clinical trials of immunotherapy in triple-negative breast cancerFrederick M Howard, Alexander T Pearson, Rita NandaExpert Review of Anticancer Therapy|November 21, 2022
The evolving therapeutic landscape of antibody-drug conjugates in breast cancerNan Chen, Elena Michaels, Frederick Howard, et al.Pageof 15